Cargando…

Long-term outcome among men with conservatively treated localised prostate cancer

Optimal management of clinically localised prostate cancer presents unique challenges, because of its highly variable and often indolent natural history. There is an urgent need to predict more accurately its natural history, in order to avoid unnecessary treatment. Medical records of men diagnosed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuzick, J, Fisher, G, Kattan, M W, Berney, D, Oliver, T, Foster, C S, Møller, H, Reuter, V, Fearn, P, Eastham, J, Scardino, P
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360576/ https://www.ncbi.nlm.nih.gov/pubmed/17077805 http://dx.doi.org/10.1038/sj.bjc.6603411

Ejemplares similares

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study
por: Berney, D M, et al.
Publicado: (2009)

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2013)

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort
por: Fisher, G, et al.
Publicado: (2013)

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2012)

Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome
por: Berney, Daniel M, et al.
Publicado: (2016)

Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2015)

Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? correlation with outcome in biopsy cases treated conservatively
por: Ahmad, Amar S., et al.
Publicado: (2018)

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
por: Reid, A H M, et al.
Publicado: (2010)

Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement
por: Foster, C S, et al.
Publicado: (2009)

Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy
por: Cuzick, Jack M., et al.
Publicado: (2021)

The percentage of high‐grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death
por: Berney, Daniel M, et al.
Publicado: (2019)

Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer
por: Merson, S, et al.
Publicado: (2014)

A randomised trial of robotic and open prostatectomy in men with localised prostate cancer
por: Gardiner, Robert A, et al.
Publicado: (2012)

Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer
por: Ahmad, I, et al.
Publicado: (2013)

A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factors
por: Ahmad, Amar S., et al.
Publicado: (2016)

Multimodality imaging using proton magnetic resonance spectroscopic imaging and (18)F-fluorodeoxyglucose-positron emission tomography in local prostate cancer
por: Shukla-Dave, Amita, et al.
Publicado: (2017)

ProsCan for Men: Randomised controlled trial of a decision support intervention for men with localised prostate cancer
por: Chambers, Suzanne K, et al.
Publicado: (2008)

Current strategies for monitoring men with localised prostate cancer lack a strong evidence base: observational longitudinal study
por: Metcalfe, C, et al.
Publicado: (2009)

Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer
por: Attard, G, et al.
Publicado: (2008)

DNA methylation gene-based models indicating independent poor outcome in prostate cancer
por: Vasiljević, Nataša, et al.
Publicado: (2014)

My Road Ahead study protocol: a randomised controlled trial of an online psychological intervention for men following treatment for localised prostate cancer
por: Wootten, Addie C, et al.
Publicado: (2014)

Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer
por: King, M T, et al.
Publicado: (2012)

Feasibility study of a randomised controlled trial to compare (deferred) androgen deprivation therapy and cryotherapy in men with localised radiation-recurrent prostate cancer
por: Salji, M, et al.
Publicado: (2014)

Prostate cancer–Exercise and Metformin Trial (Pre-EMpT): study protocol for a feasibility factorial randomized controlled trial in men with localised or locally advanced prostate cancer
por: McGeagh, Lucy, et al.
Publicado: (2022)

Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer
por: Vasiljević, N, et al.
Publicado: (2013)

Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms
por: Tzeng, Michael, et al.
Publicado: (2021)

A Pilot retrospective analysis of alpha-blockers on recurrence in men with localised prostate cancer treated with radiotherapy
por: Hart, Jordan, et al.
Publicado: (2020)

Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer
por: Stankiewicz, Elzbieta, et al.
Publicado: (2017)

Efficacy and toxicity of external-beam radiation therapy for localised prostate cancer: a network meta-analysis
por: Zhu, Z, et al.
Publicado: (2014)

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study
por: Catto, J W F, et al.
Publicado: (2011)

ProsCan for Couples: Randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer who receive radical prostatectomy
por: Chambers, Suzanne K, et al.
Publicado: (2008)

Development of a Nomogram Model Predicting Current Bone Scan Positivity in Patients Treated with Androgen-Deprivation Therapy for Prostate Cancer
por: Gotto, Geoffrey T., et al.
Publicado: (2014)

Protocol for a prospective study evaluating circulating tumour cells status to predict radical prostatectomy treatment failure in localised prostate cancer patients (C-ProMeta-1)
por: Al-Hammouri, Tarek, et al.
Publicado: (2023)

Men's help‐seeking in the first year after diagnosis of localised prostate cancer
por: Hyde, M.K., et al.
Publicado: (2016)

The experiences of giving and receiving social support for men with localised prostate cancer and their partners
por: Nelson, Kayleigh, et al.
Publicado: (2019)

A Case of Definitive Therapy for Localised Prostate Cancer: Report of a Urological Nightmare
por: Sommerhuber, Andreas, et al.
Publicado: (2012)

Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223
por: Hijab, Adham, et al.
Publicado: (2021)

Outcomes of salvage radical prostatectomy following more than one failed local therapy
por: Sivaraman, Arjun, et al.
Publicado: (2018)

Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?
por: Sivaraman, Arjun, et al.
Publicado: (2018)

Baseline psychosocial predictors of survival in localised breast cancer
por: Lehto, U-S, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_r63t60p6gopj3b9evkj59ui1gb